Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05641558 · COMPLETED
Trial details
- NCT number
- NCT05641558
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2022-10-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.